What is the likely diagnosis and recommended management for a patient presenting with non‑pruritic hypopigmented or erythematous plaques on the cheeks, elbows, and tibial shin accompanied by loss of sensation over the lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leprosy (Hansen's Disease)

The clinical presentation of non-pruritic skin lesions on the cheeks, elbows, and tibial shin with associated numbness over the lesions is pathognomonic for leprosy (Hansen's disease), and the patient requires immediate referral to a specialized leprosy treatment center for multidrug therapy with dapsone, rifampin, and clofazimine. 1, 2

Diagnostic Features

The combination of hypopigmented or erythematous plaques with loss of sensation is virtually diagnostic of leprosy and distinguishes it from all other dermatologic conditions:

  • Sensory loss over skin lesions is the hallmark feature that differentiates leprosy from other hypopigmented or erythematous disorders 3, 2
  • The distribution on cheeks, elbows, and tibial shin (cooler body areas) is characteristic, as Mycobacterium leprae preferentially affects these sites 3, 2
  • Absence of pruritus is typical for leprosy lesions, unlike eczematous or allergic conditions 2
  • Lesions may appear as hypopigmented or erythematous patches and plaques, occasionally with minimal scaling 3, 2

Critical Examination Steps

Perform these specific assessments immediately:

  • Test sensation within each lesion using light touch and pinprick to document anesthesia 2
  • Palpate peripheral nerves (ulnar, radial cutaneous, common peroneal, posterior tibial) for thickening or tenderness 1
  • Examine the entire body for additional lesions, particularly on cooler areas (face, ears, extensor surfaces) 3
  • Assess for nerve function deficits including weakness in hands or feet, which indicates neuritis requiring urgent treatment 1

Differential Diagnosis Exclusions

While other conditions may superficially resemble these lesions, the presence of numbness excludes them:

  • Pityriasis alba presents with hypopigmented patches but maintains normal sensation and occurs primarily in children 4
  • Lichen planus can present with hypopigmented lesions but is typically pruritic and lacks sensory changes 5, 6
  • Psoriasis presents with erythematous plaques on elbows but has thick silvery scale, is pruritic, and has normal sensation 7, 8
  • Lyme disease erythema migrans is expanding, typically >5 cm, and lacks sensory loss 7

Immediate Management Algorithm

Step 1: Confirm diagnosis

  • Perform slit-skin smear from lesion edges and earlobes for acid-fast bacilli 2
  • Obtain punch biopsy showing granulomatous inflammation with perineural infiltration 3, 2

Step 2: Classify disease type

  • Paucibacillary (tuberculoid): Few lesions (<5), negative skin smears, requires 6 months treatment 1
  • Multibacillary (lepromatous/borderline): Multiple lesions (≥5), positive smears, requires 12 months treatment 1

Step 3: Initiate multidrug therapy immediately

  • Contact specialized leprosy treatment center (USPHS Carville, LA in United States) for treatment protocols 1
  • Standard regimen combines dapsone, rifampin, and clofazimine 1

Critical Management Pitfalls

Monitor for reactional states during treatment:

  • Type 1 reversal reaction: Swelling of existing lesions with neuritis occurring soon after treatment initiation requires high-dose corticosteroids to prevent permanent nerve damage 1
  • Type 2 reaction (erythema nodosum leprosum): Fever with tender erythematous nodules occurs in ~50% of lepromatous patients in first year, requiring hospitalization if severe 1
  • Neuritis is a medical emergency: Any nerve pain, tenderness, or new weakness requires immediate corticosteroid therapy and possible surgical decompression to prevent irreversible disability 1

Continue anti-leprosy treatment throughout reactional states unless specifically contraindicated, as stopping therapy worsens outcomes 1

References

Research

Nonpruritic erythematous plaques.

The Journal of family practice, 2009

Research

Verrucous lesions in leprosy.

International journal of mycobacteriology, 2020

Research

Hypopigmented Macules as Manifestation of Lichen Planus and Lichen Planopilaris.

The American Journal of dermatopathology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Distinguishing and Managing Scalp Psoriasis vs Seborrheic Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best natural treatment for pityriasis alba using a gut health improvement program to reduce systemic inflammation?
What are the clinical characteristics of lichen planus on the lower extremity?
What are the clinical features of pityriasis alba, particularly in children, young adults, and the extensive adult variant?
What are the characteristic findings of Pityriasis (Pityriasis) Alba on physical exam?
What is the best management approach for a patient with Actinic Lichen Planus (LP) on the face, with a possible history of lipoma and potential lipid disorders?
In an adult (especially >65) patient, can diazepam be used for travel (motion) sickness, and what dose, contraindications (e.g., COPD, sleep apnea, hepatic impairment, pregnancy, benzodiazepine dependence) and alternative therapies should be considered?
Could the seminal vesicle inflammation in a man who recently recovered from acute Escherichia coli prostatitis be sterile (non‑infectious) rather than a bacterial infection?
What community‑based interventions are recommended to prevent and treat chronic malnutrition (stunting, underweight, micronutrient deficiencies) in children under five living in low‑ and middle‑income settings?
In a patient with an acute gastrointestinal bleed, should tranexamic acid be administered?
What does the ELNT regimen entail for a patient with rheumatic heart disease, mitral‑valve replacement, atrial fibrillation, and acute pulmonary edema?
What lifestyle measures should be recommended for a 72‑year‑old woman with polycythemia vera who is being treated with hydroxyurea (Hydrea)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.